Transplantation proceedings · 2026
Changes in Patient Symptoms After Kidney Transplantation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
King Catherine P, Cossart Amelia R, Isbel Nicole M, Campbell Scott B, Taing Meng-Wong, Leary Diana, Houlihan Vincent, Staatz Christine E
Аннотация
BACKGROUND: Immunosuppressant usage in kidney transplant recipients is commonly associated with toxicity which can manifest in a variety of adverse effects. This study aimed to compare the nature and frequency of patient-reported symptoms before and after kidney transplantation.
METHODS: A single-center study was conducted involving adult kidney transplant recipients at 3 to 11 weeks post-transplantation. Patients completed a questionnaire pertaining to the prevalence of symptoms experienced a few months before and since transplantation. A paired Student's t-test and Wilcoxon signed-rank tests were used to identify changes in the number and frequency of symptoms, respectively, with a p-value <.05 considered statistically significant.
RESULTS: Eighty patients completed this non-interventional study. While a similar number of symptoms (mean ± standard deviation) were experienced before and after transplantation (9.9 ± 4.8 and 9.0 ± 4.7, respectively; p = .098) there was a shift in the frequency of symptoms. Since transplantation, there was an improvement (reduced frequency) in itch (p ≤ .001), tiredness/fatigue (p = .045), nausea (p ≤ .001), headache/migraine (p ≤ .001), fidgetiness/restlessness (p = .018) and mind going blank (p = .022). However, hand tremor (p ≤.001), tremor elsewhere (p ≤.001), waking at night (p ≤.001), and dysesthesia (thermodysregulation and paresthesia) (p = .008) worsened (increased frequency), as reported by 75%, 26%, 45%, and 38% of patients, respectively.
CONCLUSION: Many patients experience tremor and dysesthesia as new symptoms or report them more frequently early after transplantation. Further research into understanding and managing these toxicities over this period is warranted.
METHODS: A single-center study was conducted involving adult kidney transplant recipients at 3 to 11 weeks post-transplantation. Patients completed a questionnaire pertaining to the prevalence of symptoms experienced a few months before and since transplantation. A paired Student's t-test and Wilcoxon signed-rank tests were used to identify changes in the number and frequency of symptoms, respectively, with a p-value <.05 considered statistically significant.
RESULTS: Eighty patients completed this non-interventional study. While a similar number of symptoms (mean ± standard deviation) were experienced before and after transplantation (9.9 ± 4.8 and 9.0 ± 4.7, respectively; p = .098) there was a shift in the frequency of symptoms. Since transplantation, there was an improvement (reduced frequency) in itch (p ≤ .001), tiredness/fatigue (p = .045), nausea (p ≤ .001), headache/migraine (p ≤ .001), fidgetiness/restlessness (p = .018) and mind going blank (p = .022). However, hand tremor (p ≤.001), tremor elsewhere (p ≤.001), waking at night (p ≤.001), and dysesthesia (thermodysregulation and paresthesia) (p = .008) worsened (increased frequency), as reported by 75%, 26%, 45%, and 38% of patients, respectively.
CONCLUSION: Many patients experience tremor and dysesthesia as new symptoms or report them more frequently early after transplantation. Further research into understanding and managing these toxicities over this period is warranted.